No Prescription |
 |
 | ||
|
Pravachol Prava |
|
| ||
No Prescription » Prescription Drugs 13 » Pravachol Prava Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Pravachol (pravastatin sodium) is prescribed to patients who have elevated levels of cholesterol that cannot be controlled through diet and exercise alone. For patients with normal cholesterol (total cholesterol less than 240 mg/dL) and previous heart attack Pravachol is indicated in addition to diet to reduce the risk of recurrent heart attack; the risk of stroke/mini-stroke; the risk of undergoing heart surgery such as bypass and angioplasty. For patients with elevated cholesterol and evidence of coronary heart disease Pravachol is indicated in addition to diet to slow the progression of atherosclerosis and to reduce the risk of recurrent heart attacks. For patients with elevated cholesterol and no previous heart attack Pravachol is indicated in addition to diet to reduce the risk of heart attack; the risk of death from heart disease; and the risk of undergoing heart surgery such as bypass and angioplasty. Hypercholesterolaemia. Post MI (includes combination with aspirin). Lowering high cholesterol and triglycerides in certain patients. It also increases high-density lipoprotein (HDL "good") cholesterol levels. It is used along with an appropriate diet. It is also used in certain patients to reduce the risk of heart attack stroke and death due to coronary heart disease. It is also used to slow blood vessel blockage and to reduce the need for medical procedures to open blocked blood vessels. Buy Pravachol Prava and other Prescription Drugs 13 products online at Medstore. 3706
About Pravachol Prava: Product Type: Prescription Drugs 13 Pravachol ( Prava Generic Pravastatin ) Pravachol (Prava Generic Pravastatin) Prava Generic Pravastatin 20mg 20 Tablets Prava Generic Pravastatin Pravachol
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
